Frankfurt
23.09.26 | 08:00
0,149 Euro
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Vext Science Inc: Vext Science reopens Jackson, Ohio, dispenary | 1 | Stockwatch | ||
| Do | VEXT Science, Inc.: Vext Announces Reopening of Jackson, Ohio Dispensary and Restructuring of Ohio Seller Notes Ahead of December 2026 Maturity | 483 | Newsfile | Ohio Division of Cannabis Control authorizes reopening of Jackson dispensary effective September 17Single-day obligation at maturity reduced from approximately US$5.6 million to US$2.4 million, payable... ► Artikel lesen | |
| 05.09. | Vext Science Inc: Vext closes Jackson dispensary over two adverse events | 1 | Stockwatch | ||
| 04.09. | VEXT Science, Inc.: Vext Provides Operational Update on Jackson, Ohio Dispensary | 968 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - September 4, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based specialty retailer operating in the regulated... ► Artikel lesen | |
| VEXT SCIENCE Aktie jetzt für 0€ handeln | |||||
| 20.08. | Vext Science reports Q2 results | 2 | Seeking Alpha | ||
| 20.08. | VEXT Science, Inc.: Vext Reports Q2 2026 Financial Results; Opens Sixth Ohio Dispensary, Completes Arizona Cultivation Wind-Down; Adjusted EBITDA Grows for Second Consecutive Quarter | 1.029 | Newsfile | Revenue of $12.1 million, level with Q1 2026, as Ohio growth offset the planned Arizona cultivation wind-down.Adjusted EBITDA* of $3.4 million, up 22% from Q1 2026; net loss narrowed 79% year-over-year... ► Artikel lesen | |
| 13.08. | Vext Science Inc: Vext Science to release Q2 results on Aug. 20 | 1 | Stockwatch | ||
| 12.08. | VEXT Science, Inc.: Vext Announces Date for Q2 2026 Financial Results Release | 682 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - August 12, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator in Arizona and Ohio, today... ► Artikel lesen | |
| 02.06. | VEXT Science, Inc.: Vext Opens Sixth Ohio Dispensary in Fairfield | 548 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 1, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with operations in Arizona... ► Artikel lesen | |
| 21.05. | Vext Science reports Q1 results | 5 | Seeking Alpha | ||
| 21.05. | VEXT Science, Inc.: Vext Reports Q1 2026 Financial Results; Adjusted EBITDA up 73% Sequentially to $3.6 Million as Ohio Platform Scales | 900 | Newsfile | Revenue of $12.2 million, up 5.2% year-over-year; gross profit more than doubled to $5.5 million (45.4% margin), and net loss narrowed 73.2% to $(0.9) million.Operating cash flow of $1.6 million... ► Artikel lesen | |
| 15.05. | Vext Science Inc: Vext Science hires Zuanic & Associates for IR | 2 | Stockwatch | ||
| 15.05. | VEXT Science, Inc.: Vext Engages Zuanic & Associates | 585 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - May 15, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator with operations in Arizona and... ► Artikel lesen | |
| 14.05. | VEXT Science, Inc.: Vext Announces Date for Q1 2026 Financial Results Release | 702 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - May 14, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator in Arizona and Ohio, today announced... ► Artikel lesen | |
| 30.04. | Vext Science reports Q4 results | 1 | Seeking Alpha | ||
| 29.04. | VEXT Science, Inc.: Vext Reports Q4 and FY 2025; Fiscal 2025 Revenue up +43% to $51.4M, Operating Cash Flow up +256% to $11.7M as Ohio Retail Scales | 409 | Newsfile | Fiscal 2025 revenue of $51.4 million, up +43% YoY, with EBITDA* of $5 million and Adjusted EBITDA* of $10.9 million; net cash provided by operating activities of $11.7 million, up +256% (+$8.4 million)... ► Artikel lesen | |
| 22.04. | Vext Science Inc: Vext revises 2025 results release date to April 29 | 1 | Stockwatch | ||
| 21.04. | VEXT Science, Inc.: Vext Announces Revised Date for Q4 and Fiscal 2025 Financial Results Release | 466 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - April 21, 2026) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company") a U.S.-based cannabis operator in Arizona and Ohio, today... ► Artikel lesen | |
| 30.03. | Vext Science Inc: Vext to discontinue operations at Arizona facility | 1 | Stockwatch | ||
| 30.03. | VEXT Science, Inc.: Vext Science Announces Strategic Optimization of Arizona Operations and Plans for Ohio Cultivation Expansion | 2.393 | Newsfile | Strategic closure and planned sale of Eloy cultivation facility expected to improve Arizona profitability and enhance free cash flow.Proceeds from the sale to facilitate debt reduction, with key... ► Artikel lesen |
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,656 | -1,88 % | Aurora Cannabis: Prognose hält - warum fällt die Aktie? | ||
| CANOPY GROWTH | 0,842 | +0,07 % | Canopy enters UK medical cannabis market with distribution deal | ||
| TILRAY BRANDS | 3,680 | -0,54 % | Tilray Brands, Inc.: BrewDog Launches 'Under New Ownership' Campaign, Marking a New Era of Fresh Energy, New Backing and Award-Winning Beer | Under Tilray ownership, BrewDog is back on the front foot - with fresh investment, renewed energy and award-winning beers driving the next chapter for one of the UK and Europe's biggest craft beer brands.
ELLON... ► Artikel lesen | |
| INNOCAN PHARMA | 1,300 | -11,56 % | Innocan Pharma: Kapitalrunde setzt Anleger unter Zugzwang | ||
| CRONOS GROUP | 3,054 | +2,07 % | Cronos Group Inc.: Cronos Group Reports 2026 Second Quarter Results | Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q2 2026 increased by 51% year-over-year on an organic, constant-currency basis... ► Artikel lesen | |
| SYNBIOTIC | 0,900 | +1,12 % | Original-Research: SYNBIOTIC SE (von NuWays AG): Under review | Original-Research: SYNBIOTIC SE - from NuWays AG
24.08.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for... ► Artikel lesen | |
| DIGICANN VENTURES | 0,005 | 0,00 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 0,943 | 0,00 % | Organigram Global Inc.: Organigram Global treibt die Integration der Sanity Group unter einer einheitlichen globalen Betriebsstruktur voran | Führung, operatives Geschäft und Marktentwicklung werden über eine globale Plattform aufeinander abgestimmt, die Kanada mit Deutschland und anderen wichtigen internationalen Märkten verbindet
Die... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 6,690 | +1,67 % | Green Thumb Industries to Report Third Quarter 2026 Financial Results on November 4, 2026 | ||
| SNDL | 1,221 | 0,00 % | Immortal Dragons: Sundial Initiative Advisor Boyang Wang Sponsors Nakauchi Lab's Work on "Bodyoids" | SINGAPORE, SG / ACCESS Newswire / July 30, 2026 / Boyang Wang, advisor to the Sundial Initiative and founder and CEO of the longevity fund Immortal Dragons, has sponsored the Nakauchi Lab, led by stem... ► Artikel lesen | |
| CRESCO LABS | 0,699 | +2,34 % | Cresco Labs Inc: Cresco Labs appoints Tilly as independent director | ||
| NOVERIS HEALTH SCIENCES | 0,068 | -2,86 % | Noveris Health Sciences Inc.: Noveris Health Sciences Announces Results of 2026 Annual General and Special Meeting | Vancouver, British Columbia--(Newsfile Corp. - September 9, 2026) - Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") announces the results of its annual... ► Artikel lesen | |
| QUANTUM BIOPHARMA | 3,088 | -2,59 % | Rodman & Renshaw Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$8 Price Target | TORONTO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of... ► Artikel lesen | |
| HAPPY BELLY FOOD GROUP | 0,920 | +1,10 % | Happy Belly Food Group Inc.: Happy Belly Food Group's Heal Wellness QSR Signs First Franchise Agreement in Province of New Brunswick | Toronto, Ontario--(Newsfile Corp. - September 22, 2026) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leading consolidator of emerging restaurant brands... ► Artikel lesen | |
| COMPASS PATHWAYS | 12,900 | -0,77 % | Compass Pathfinder Limited: Compass Pathways to Participate in TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit on September 23, 2026 | Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that management will attend the TD... ► Artikel lesen |
VEXT SCIENCE INC gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,149 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VEXT SCIENCE INC finden Sie auf Wallstreet Online.